UASt regulatory sequences drive expression of an inverted repeat.
Expression of Rac2GD17536 under the control of Scer\GAL4Hml.Δ results in significantly reduced survival when infected with Leishmania amastigotes, as compared to wild type.
Expression of Rac2GD17536 under the control of Scer\GAL4Vm26Aa.F results in moderate dorsal appendage defects in 56% of cases and strong defects in 8% of cases, with the appendages being rough.
Expression of Rac2GD17536 under the control of Scer\GAL4CY2 results in moderate dorsal appendage defects in 36% of cases and strong defects in 11% of cases, with the appendages having a wide base.
Larvae expressing Rac2GD17536 under the control of Scer\GAL4Hml.PG show strongly reduced encapsulation (1%) of eggs when parasitised by the avirulent L. boulardi wasp strain G486. Plasmatocytes fully cover the egg, while lamellocytes partially cover it.
Expression of Rac2GD17536 under the control of Scer\GAL4pnr.PU results in loss of microchaetae and an absence of dorso-anterior macrochaetae in the central part of the notum.
Adults expressing Rac2GD17536 under the control of Scer\GAL4elav.PLu (in the presence of Dcr-2Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.
Expression under the control of Scer\GAL4pnr-MD237 results in loss of bristles on the notum in 90-100% of the Scer\GAL4pnr-MD237 expression domain.
Expression under the control of Scer\GAL4pnr-MD237 results in the absence of 20-30% of the Scer\GAL4pnr-MD237-expressing area of the notum.
Rac2GD17536, Scer\GAL4pnr.PU has visible phenotype, non-suppressible by Cul4[+]/Cul4G1-3
Rac2GD17536, Scer\GAL4pnr.PU has visible phenotype, non-suppressible by l(2)dtlc02261/l(2)dtl[+]
Rac2GD17536, Scer\GAL4pnr.PU has visible phenotype, non-suppressible by l(2)dtlNIG.11295R, Scer\GAL4pnr.PU
Scer\GAL4Cg.PA, MtlKK110274/Rac2GD17536 is a non-enhancer of increased cell number | third instar larval stage phenotype of Gyc76CUAS.Tag:MYC, Scer\GAL4Cg.PA
Rac2GD17536, Scer\GAL4Cg.PA is a non-enhancer of increased cell number | third instar larval stage phenotype of Gyc76CUAS.Tag:MYC, Scer\GAL4Cg.PA
Rac2GD17536, Scer\GAL4Cg.PA is a non-suppressor of increased cell number | third instar larval stage phenotype of Gyc76CUAS.Tag:MYC, Scer\GAL4Cg.PA
Scer\GAL4Cg.PA, MtlKK110274/Rac2GD17536 is a non-suppressor of increased cell number | third instar larval stage phenotype of Gyc76CUAS.Tag:MYC, Scer\GAL4Cg.PA
Rac2GD17536, Scer\GAL4Vm26Aa.F has dorsal appendage phenotype, enhanceable by ttk[+]/ttktwp
Rac2GD17536, Scer\GAL4CY2 has dorsal appendage phenotype, enhanceable by ttk[+]/ttktwp
Rac2GD17536, Scer\GAL4pnr.PU has microchaeta phenotype, non-suppressible by Cul4[+]/Cul4G1-3
Rac2GD17536, Scer\GAL4pnr.PU has anterior dorsocentral bristle phenotype, non-suppressible by Cul4[+]/Cul4G1-3
Rac2GD17536, Scer\GAL4pnr.PU has microchaeta phenotype, non-suppressible by l(2)dtlc02261/l(2)dtl[+]
Rac2GD17536, Scer\GAL4pnr.PU has anterior dorsocentral bristle phenotype, non-suppressible by l(2)dtlc02261/l(2)dtl[+]
Rac2GD17536, Scer\GAL4pnr.PU has microchaeta phenotype, non-suppressible by l(2)dtlNIG.11295R, Scer\GAL4pnr.PU
Rac2GD17536, Scer\GAL4pnr.PU has anterior dorsocentral bristle phenotype, non-suppressible by l(2)dtlNIG.11295R, Scer\GAL4pnr.PU
Scer\GAL4Cg.PA, MtlKK110274/Rac2GD17536 is a non-enhancer of embryonic/larval hemocyte | third instar larval stage | increased number phenotype of Gyc76CUAS.Tag:MYC, Scer\GAL4Cg.PA
Rac2GD17536, Scer\GAL4Cg.PA is a non-enhancer of embryonic/larval hemocyte | third instar larval stage | increased number phenotype of Gyc76CUAS.Tag:MYC, Scer\GAL4Cg.PA
Rac2GD17536, Scer\GAL4Cg.PA is a non-suppressor of embryonic/larval hemocyte | increased number | third instar larval stage phenotype of Gyc76CUAS.Tag:MYC, Scer\GAL4Cg.PA
Scer\GAL4Cg.PA, MtlKK110274/Rac2GD17536 is a non-suppressor of embryonic/larval hemocyte | increased number | third instar larval stage phenotype of Gyc76CUAS.Tag:MYC, Scer\GAL4Cg.PA
The severity of the dorsal appendage defects caused by expression of Rac2GD17536 under the control of either Scer\GAL4Vm26Aa.F or Scer\GAL4CY2 is enhanced by ttktwp/+.